Kiniksa Pharmaceuticals International (KNSA) EPS (Basic) (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) posted EPS (Basic) of $0.3 for Q1 2026, down 27.79% on a QoQ basis from $0.41 in Q4 2025, and up 151.19% year-over-year from $0.12 in Q1 2025.
Kiniksa Pharmaceuticals International (KNSA) EPS (Basic) (2017 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International's EPS (Basic) history runs 10 years deep, the most recent figure standing at $0.3 for Q1 2026.
- Quarterly EPS (Basic) rose 151.19% year-over-year to $0.3 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.17 (up 634.61% YoY) and the FY2025 annual result came in at $1.01, up 591.55% from the prior year.
- EPS (Basic) was $0.3 for Q1 2026 at Kiniksa Pharmaceuticals International, down from $0.41 in the prior quarter.
- Across five years, EPS (Basic) topped out at $3.23 in Q3 2022 and bottomed at -$3.98 in Q4 2022.
- A 5-year average of -$0.1 and a median of -$0.06 in 2024 frame the typical range for EPS (Basic).
- Peak annual rise in EPS (Basic) reached 825.41% in 2022, while the deepest fall reached 519.33% in 2022.
- Kiniksa Pharmaceuticals International's EPS (Basic) stood at -$3.98 in 2022, then surged by 70.22% to -$1.19 in 2023, then soared by 123.14% to $0.27 in 2024, then jumped by 49.07% to $0.41 in 2025, then decreased by 27.79% to $0.3 in 2026.
- Business Quant data shows KNSA's EPS (Basic) at $0.3 in Q1 2026, $0.41 in Q4 2025, and $0.25 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 0.32 |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 1.42 |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -1.49 |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 6.32 |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 0.15 |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 1.97 |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 0.11 |
| 10 | Kiniksa Pharmaceuticals International | 4.78 Bn | 4.31 Bn | 193.47 Mn | 0.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.30 |
| Dec 31, 2025 | 0.41 |
| Sep 30, 2025 | 0.25 |
| Jun 30, 2025 | 0.24 |
| Mar 31, 2025 | 0.12 |
| Dec 31, 2024 | 0.27 |
| Sep 30, 2024 | -0.18 |
| Jun 30, 2024 | -0.06 |
| Mar 31, 2024 | -0.25 |
| Dec 31, 2023 | -1.19 |
| Sep 30, 2023 | -0.20 |
| Jun 30, 2023 | 0.21 |
| Mar 31, 2023 | -0.18 |
| Dec 31, 2022 | -3.98 |
| Sep 30, 2022 | 3.23 |
| Jun 30, 2022 | -0.29 |
| Mar 31, 2022 | -0.36 |
| Dec 31, 2021 | -0.64 |
| Sep 30, 2021 | -0.44 |
| Jun 30, 2021 | -0.61 |